Publications by authors named "Susanne Reschke"

Claim this Profile
A
A phase I pharmacokinetic study of copanlisib in Chinese patients with relapsed indolent non-Hodgkin lymphoma.
Weiping Liu, Lingyan Ping, Yan Xie, Yingli Sun, Tingting Du, Susanne Reschke

Cancer Chemother Pharmacol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Pharmacokinetics of the Androgen Receptor Inhibitor Darolutamide in Healthy Subjects and Patients with Hepatic or Renal Impairment.
Christian Zurth, Pirjo Nykänen, Gary Wilkinson, Päivi Taavitsainen, Annamari Vuorela, Susanne Reschke

Clin Pharmacokinet· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I Assessment of Safety and Therapeutic Activity of BAY1436032 in Patients with IDH1-Mutant Solid Tumors.
Antje Wick, Oliver Bähr, Martin Schuler, Kristoffer Rohrberg, Sant P Chawla, Susanne Reschke

Clin Cancer Res· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Phase Ib Trial of the PI3K Inhibitor Copanlisib Combined with the Allosteric MEK Inhibitor Refametinib in Patients with Advanced Cancer.
Ramesh K Ramanathan, Daniel D Von Hoff, Ferry Eskens, George Blumenschein, Donald Richards, Susanne Reschke

Target Oncol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase Ib Trial of the PI3K Inhibitor Copanlisib Combined with the Allosteric MEK Inhibitor Refametinib in Patients with Advanced Cancer.
Ramesh K Ramanathan, Daniel D Von Hoff, Ferry Eskens, George Blumenschein, Donald Richards, Susanne Reschke

Target Oncol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
On-Target Pharmacodynamic Activity of the PI3K Inhibitor Copanlisib in Paired Biopsies from Patients with Malignant Lymphoma and Advanced Solid Tumors.
Franck Morschhauser, Jean-Pascal Machiels, Gilles Salles, Sylvie Rottey, Simon A J Rule, Susanne Reschke

Mol Cancer Ther· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of intravenous pan-class I phosphatidylinositol 3-kinase (PI3K) inhibitor [C]copanlisib (BAY 80-6946) in a mass balance study in healthy male volunteers.
Michael Gerisch, Thomas Schwarz, Dieter Lang, Gabriele Rohde, Stefanie Reif, Susanne Reschke

Cancer Chemother Pharmacol· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thoracic empyema after pneumonectomy: intrathoracic application of vacuum-assisted closure therapy.
Christian Renner, Susanne Reschke, Wolfgang Richter

Ann Thorac Surg· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis